Regenxbio (RGNX) Return on Invested Capital (2019 - 2022)
Regenxbio (RGNX) recorded quarterly Return on Invested Capital of 0.0% in Q4 2022, down 1.07% quarter-over-quarter from 0.0% in Q3 2022, and little changed on a YoY basis from 0.0% in Q4 2021.
Regenxbio (RGNX) Return on Invested Capital (2019 - 2022) Analysis & Trends
Regenxbio's Return on Invested Capital history runs 4 years deep, the most recent figure standing at 0.0% for Q4 2022.
- In Q4 2022, Return on Invested Capital changed 0.0% year-over-year to 0.0%; the TTM figure through Dec 2022 stood at 0.0% (changed 0.0% YoY), while the FY2023 annual figure was 0.01%, down 1.0% from the prior year.
- Return on Invested Capital was 0.0% for Q4 2022 at Regenxbio, down from 0.0% in the prior quarter.
- In the past five years, Return on Invested Capital ranged from a high of 0.16% in Q4 2019 to a low of 0.17% in Q4 2020.
- Historically, Return on Invested Capital has averaged 0.0% across 4 years, with a median of 0.0% in 2021.
- The sharpest annual moves came in 2020 and 2021: Return on Invested Capital tumbled 33 bps in 2020, then increased 18 bps in 2021.
- A 4-year view of Return on Invested Capital shows it stood at 0.16% in 2019, then sank by 211 bps to 0.17% in 2020, then surged by 101 bps to 0.0% in 2021, then sank by 36 bps to 0.0% in 2022.
- The last three Return on Invested Capital figures came in at 0.0% (Q4 2022), 0.0% (Q3 2022), and 0.0% (Q2 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 0.01% |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -0.01% |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -0.01% |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 0.00% |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Regenxbio | 315.11 Mn | 85.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |
| Jun 30, 2021 | 0.00% |
| Mar 31, 2021 | 0.00% |
| Dec 31, 2020 | -0.17% |
| Sep 30, 2020 | -0.01% |
| Jun 30, 2020 | 0.00% |
| Dec 31, 2019 | 0.16% |
| Sep 30, 2019 | 0.00% |
| Jun 30, 2019 | 0.00% |
| Mar 31, 2019 | 0.00% |